US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 20.730
  • -1.390-6.28%
Close Jun 14 16:00 ET
  • 20.330
  • -0.400-1.93%
Post 16:06 ET
2.96BMarket Cap-22053P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
204.74%330.53M
0
-64.40%1.27M
460.45%294.12M
-16.61%35.14M
122.90%108.46M
-17.83%10.28M
-32.66%3.56M
128.78%52.48M
Operating revenue
--0
214.60%330.53M
--0
588.59%1.27M
460.45%294.12M
-16.61%35.14M
115.93%105.07M
-18.01%10.26M
-96.52%184K
128.81%52.48M
Cost of revenue
Gross profit
Operating expense
-15.20%132.25M
17.37%527.23M
14.65%132.57M
3.62%115.06M
8.56%123.64M
43.55%155.96M
30.43%449.21M
29.00%115.63M
22.19%111.05M
34.38%113.9M
Selling and administrative expenses
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
14.44%90.48M
8.07%23.52M
20.39%23.26M
11.10%21.16M
-General and administrative expense
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
14.44%90.48M
8.07%23.52M
20.39%23.26M
11.10%21.16M
Research and development costs
-16.92%107.02M
18.16%423.88M
17.04%107.8M
2.22%89.74M
5.16%97.52M
49.62%128.82M
35.19%358.73M
35.70%92.11M
22.68%87.79M
41.13%92.74M
Operating profit
-9.47%-132.25M
42.27%-196.7M
-25.85%-132.57M
-5.87%-113.8M
377.59%170.48M
-81.68%-120.82M
-15.21%-340.74M
-36.60%-105.34M
-25.58%-107.49M
0.65%-61.42M
Net non-operating interest income expense
44.22%15.91M
248.62%51.51M
97.13%13.13M
244.92%14.44M
386.98%12.9M
763.38%11.03M
221.52%14.77M
418.29%6.66M
316.62%4.19M
135.26%2.65M
Non-operating interest income
44.22%15.91M
248.62%51.51M
----
----
386.98%12.9M
763.38%11.03M
221.52%14.77M
----
----
135.26%2.65M
Total other finance cost
----
----
----
-244.92%-14.44M
----
----
----
----
-316.62%-4.19M
----
Other net income (expense)
14.54M
Special income (charges)
--14.54M
----
----
----
----
--0
----
----
----
----
-Gain on sale of business
--14.54M
----
----
----
----
--0
----
----
----
----
Income before tax
7.27%-101.8M
55.46%-145.19M
-21.04%-119.44M
3.82%-99.35M
412.05%183.38M
-68.32%-109.78M
-11.96%-325.97M
-30.13%-98.68M
-22.12%-103.3M
3.17%-58.77M
Income tax
42.86%30K
600.00%30K
0
0
103.65%21K
98.96%-6K
0
27K
Net income
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
-22.12%-103.3M
3.13%-58.79M
Net income continuous Operations
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
-22.12%-103.3M
3.13%-58.79M
Minority interest income
Net income attributable to the parent company
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
-22.12%-103.3M
3.13%-58.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
-22.12%-103.3M
3.13%-58.79M
Basic earnings per share
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
379.17%1.34
-50.94%-0.8
-8.79%-2.6
-20.97%-0.75
-21.74%-0.84
4.00%-0.48
Diluted earnings per share
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
370.83%1.3
-50.94%-0.8
-8.79%-2.6
-20.97%-0.75
-21.74%-0.84
4.00%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0204.74%330.53M0-64.40%1.27M460.45%294.12M-16.61%35.14M122.90%108.46M-17.83%10.28M-32.66%3.56M128.78%52.48M
Operating revenue --0214.60%330.53M--0588.59%1.27M460.45%294.12M-16.61%35.14M115.93%105.07M-18.01%10.26M-96.52%184K128.81%52.48M
Cost of revenue
Gross profit
Operating expense -15.20%132.25M17.37%527.23M14.65%132.57M3.62%115.06M8.56%123.64M43.55%155.96M30.43%449.21M29.00%115.63M22.19%111.05M34.38%113.9M
Selling and administrative expenses -7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M14.44%90.48M8.07%23.52M20.39%23.26M11.10%21.16M
-General and administrative expense -7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M14.44%90.48M8.07%23.52M20.39%23.26M11.10%21.16M
Research and development costs -16.92%107.02M18.16%423.88M17.04%107.8M2.22%89.74M5.16%97.52M49.62%128.82M35.19%358.73M35.70%92.11M22.68%87.79M41.13%92.74M
Operating profit -9.47%-132.25M42.27%-196.7M-25.85%-132.57M-5.87%-113.8M377.59%170.48M-81.68%-120.82M-15.21%-340.74M-36.60%-105.34M-25.58%-107.49M0.65%-61.42M
Net non-operating interest income expense 44.22%15.91M248.62%51.51M97.13%13.13M244.92%14.44M386.98%12.9M763.38%11.03M221.52%14.77M418.29%6.66M316.62%4.19M135.26%2.65M
Non-operating interest income 44.22%15.91M248.62%51.51M--------386.98%12.9M763.38%11.03M221.52%14.77M--------135.26%2.65M
Total other finance cost -------------244.92%-14.44M-----------------316.62%-4.19M----
Other net income (expense) 14.54M
Special income (charges) --14.54M------------------0----------------
-Gain on sale of business --14.54M------------------0----------------
Income before tax 7.27%-101.8M55.46%-145.19M-21.04%-119.44M3.82%-99.35M412.05%183.38M-68.32%-109.78M-11.96%-325.97M-30.13%-98.68M-22.12%-103.3M3.17%-58.77M
Income tax 42.86%30K600.00%30K00103.65%21K98.96%-6K027K
Net income 7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M-22.12%-103.3M3.13%-58.79M
Net income continuous Operations 7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M-22.12%-103.3M3.13%-58.79M
Minority interest income
Net income attributable to the parent company 7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M-22.12%-103.3M3.13%-58.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M-22.12%-103.3M3.13%-58.79M
Basic earnings per share 15.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72379.17%1.34-50.94%-0.8-8.79%-2.6-20.97%-0.75-21.74%-0.844.00%-0.48
Diluted earnings per share 15.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72370.83%1.3-50.94%-0.8-8.79%-2.6-20.97%-0.75-21.74%-0.844.00%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg